a·lac·ri·ty [uh-lak-ri-tee] cheerful readiness, promptness, or willingness
Europe: London BioScience Innovation Centre 2 Royal College Street London NW1 0NH
USA: Cambridge Innovation Center 1 Broadway, 14th Floor Kendall Square, Cambridge MA 02142

changing the face
of life sciences consulting

 

Trusted people

Xavier Luria

Dr. Xavier Luria is a consultant on drug development and drug regulation. He was Head of Safety and Efficacy at the European Medicines Agency (EMA) during 2005-2012, and previously held leadership positions in the biopharmaceutical industry for more than eighteen […]

Read more »

Case studies

510(k) consulting for respiratory medical device

Alacrita's 501(k) regulatory affairs specialist supported a UK medical device company secure 510(k) clearance from FDA for a respiratory measurement device

Read more »

AAV Gene Therapy Consulting

Alacrita conducted an assessment of an AAV gene therapy for an ophthalmic indication, focusing on market potential, technical and regulatory issues and identification of key risks...

Read more »

Antibodies

Alacrita has substantial expertise in antibody discovery, development and commercialisation. We have helped a number of clients assess antibody opportunities, including target and technology assessment, strategic valuation and biosimilar market positioning...

Read more »

Business Development and Partnering Support

Alacrita provides opportunity assessment, valuation and deal structure support to both in-licensors and out-licensors. We work alongside in-house licensing and business development professionals providing real world experience and data upon which to base critical transaction decisions...

Read more »

Cancer clinical development strategy

Alacrita's expert medical team provides medical advisory services including clinical development strategy and operational Chief Medical Officer support...

Read more »